Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Henry

Showing results (611-620 of 781) with videos related to

Pageof 79
Sort By:
Open Forum Infectious Diseases|May 9, 2017
<i>Globicatella sanguinis</i> Osteomyelitis and Bacteremia: Review of an Emerging Human Pathogen with an Expanding Spectrum of DiseaseAndy O Miller, Seanne P Buckwalter, Michael W Henry, et al.
ACS Infectious Diseases|December 27, 2018
Elucidation of a Human Urine Metabolite as a Seryl-Leucine Glycopeptide and as a Biomarker of Effective Anti-Tuberculosis TherapyBryna L Fitzgerald, M Nurul Islam, Barbara Graham, et al.
Tuberculosis (Edinburgh, Scotland)|March 26, 2014
How we determined the most reliable solid medium for studying treatment of tuberculosisCharles M Heilig, Pei-Jean I Feng, Moses L Joloba, et al.
The American Journal of Tropical Medicine and Hygiene|April 12, 2012
Innate and adaptive immune responses during acute M. tuberculosis infection in adult household contacts in Kampala, UgandaC Scott Mahan, Sarah Zalwango, Bonnie A Thiel, et al.
Msystems|August 20, 2024
Epigenetic programming of host lipid metabolism associated with resistance to TST/IGRA conversion after exposure to <i>Mycobacterium tuberculosis</i>Kimberly A Dill-McFarland, Jason D Simmons, Glenna J Peterson, et al.
Antimicrobial Agents and Chemotherapy|December 23, 2017
Erratum for Alsultan et al., "Population Pharmacokinetics of AZD-5847 in Adults with Pulmonary Tuberculosis"Abdullah Alsultan, Jennifer J Furin, Jeannine Du Bois, et al.
Plos One|February 25, 2010
Tuberculosis treatment in HIV infected Ugandans with CD4 counts>350 cells/mm reduces immune activation with no effect on HIV load or CD4 countC Scott Mahan, Maria Walusimbi, Denise F Johnson, et al.
The American Journal of Sports Medicine|November 1, 2022
Factors Associated With an Intra-articular Infection After Anterior Cruciate Ligament Reconstruction: ResponseNiv Marom, Joseph T Nguyen, Milan Kapadia, et al.
Infection and Immunity|November 17, 2010
Mycobacterium tuberculosis lipoproteins directly regulate human memory CD4(+) T cell activation via Toll-like receptors 1 and 2Christina L Lancioni, Qing Li, Jeremy J Thomas, et al.
Antimicrobial Agents and Chemotherapy|July 26, 2017
Population Pharmacokinetics of AZD-5847 in Adults with Pulmonary TuberculosisAbdullah Alsultan, Jennifer J Furin, Jeannine Du Bois, et al.
Pageof 79

Showing results (611-620 of 781) with videos related to

Sort By:
Pageof 79
Open Forum Infectious Diseases|May 9, 2017
<i>Globicatella sanguinis</i> Osteomyelitis and Bacteremia: Review of an Emerging Human Pathogen with an Expanding Spectrum of DiseaseAndy O Miller, Seanne P Buckwalter, Michael W Henry, et al.
ACS Infectious Diseases|December 27, 2018
Elucidation of a Human Urine Metabolite as a Seryl-Leucine Glycopeptide and as a Biomarker of Effective Anti-Tuberculosis TherapyBryna L Fitzgerald, M Nurul Islam, Barbara Graham, et al.
Tuberculosis (Edinburgh, Scotland)|March 26, 2014
How we determined the most reliable solid medium for studying treatment of tuberculosisCharles M Heilig, Pei-Jean I Feng, Moses L Joloba, et al.
The American Journal of Tropical Medicine and Hygiene|April 12, 2012
Innate and adaptive immune responses during acute M. tuberculosis infection in adult household contacts in Kampala, UgandaC Scott Mahan, Sarah Zalwango, Bonnie A Thiel, et al.
Msystems|August 20, 2024
Epigenetic programming of host lipid metabolism associated with resistance to TST/IGRA conversion after exposure to <i>Mycobacterium tuberculosis</i>Kimberly A Dill-McFarland, Jason D Simmons, Glenna J Peterson, et al.
Antimicrobial Agents and Chemotherapy|December 23, 2017
Erratum for Alsultan et al., "Population Pharmacokinetics of AZD-5847 in Adults with Pulmonary Tuberculosis"Abdullah Alsultan, Jennifer J Furin, Jeannine Du Bois, et al.
Plos One|February 25, 2010
Tuberculosis treatment in HIV infected Ugandans with CD4 counts>350 cells/mm reduces immune activation with no effect on HIV load or CD4 countC Scott Mahan, Maria Walusimbi, Denise F Johnson, et al.
The American Journal of Sports Medicine|November 1, 2022
Factors Associated With an Intra-articular Infection After Anterior Cruciate Ligament Reconstruction: ResponseNiv Marom, Joseph T Nguyen, Milan Kapadia, et al.
Infection and Immunity|November 17, 2010
Mycobacterium tuberculosis lipoproteins directly regulate human memory CD4(+) T cell activation via Toll-like receptors 1 and 2Christina L Lancioni, Qing Li, Jeremy J Thomas, et al.
Antimicrobial Agents and Chemotherapy|July 26, 2017
Population Pharmacokinetics of AZD-5847 in Adults with Pulmonary TuberculosisAbdullah Alsultan, Jennifer J Furin, Jeannine Du Bois, et al.
Pageof 79